Read Gene

Read Gene Acquisitions (Net)

The Acquisitions (Net) of Read Gene (RDG.WA) as of Oct 16, 2026 is 287,500.00 PLN. In the previous year, Acquisitions (Net) was -871,600.00 PLN — a change of -132.99% (higher).

Acquisitions (Net)

287,500.00PLN

YoY

-132.99%

Last updated:

Acquisitions (Net) of Read Gene is 2025 287,500.00 PLN. Acquisitions (Net) of Read Gene was 2024 -871,600.00 PLN. It decreases by -132.99% higher compared to the previous year.

The Read Gene Acquisitions (Net) history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Acquisitions (Net)
Date
Acquisitions (Net)
Jan 1, 2014
0.00 PLN
Jan 1, 2015
0.00 PLN
Jan 1, 2017
0.00 PLN
Jan 1, 2018
-116,100.00 PLN
Jan 1, 2019
-147,700.00 PLN
Jan 1, 2023
-3.93 M PLN
Jan 1, 2024
-871,600.00 PLN
Jan 1, 2025
287,500.00 PLN
The Read Gene Acquisitions (Net) history
YEARAcquisitions (Net)YoY
287,500.00PLN-132.99%
-871,600.00PLN-77.81%
-3.93 MPLN+2,559.58%
-147,700.00PLN+27.22%
-116,100.00PLN—
0.00PLN—
0.00PLN—
0.00PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Read Gene Stock analysis

What does Read Gene do? Read Gene SA is a biotechnology company based in Szczecin, Poland, operating within the Health Care sector. The company went public via an IPO on February 12, 2009, and is listed under the ticker RDG.WA with ISIN PLRADGN00014. Read Gene SA focuses on medical research and testing, particularly in the fields of chemoprevention, clinical trials, and genetic testing. Its services include specialized tests for breast cancer, colon cancer, and prostate cancer, alongside medical consultancy and DNA testing. The company also provides DNA-related supplements. It operates one wholly owned subsidiary, Dieta Antyrakowa Read-Gene Sp. z o.o., and its major shareholder is GEN-PAT-MED Sp. z o.o. The company's headquarters are located in Szczecin, within the West Pomeranian Voivodeship. Read Gene SA's activities are centered on developing technologies aimed at detecting, preventing, and treating malignant tumors. The company's website is https://read-gene.com/. No additional details regarding founding year, specific products, or financial figures are provided in the source material. Read Gene is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Read Gene stock

Acquisitions (Net) of Read Gene is 287,500.00 PLN in 2025.

Acquisitions (Net) of Read Gene changed from -871,600.00 PLN to 287,500.00 PLN, representing a -132.99% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Acquisitions (Net) Read Gene since 2006 – with annual values, charts, and detailed analysis.

Net acquisitions represent the cash spent on acquiring other businesses, net of divestitures. Large acquisitions can transform a company's growth trajectory.

Acquisitions (Net)'s PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Acquisitions (Net)'s Read Gene historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Read Gene

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Read Gene